Clinical Trial Detail

NCT ID NCT02706691
Title Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients With FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Chicago

nasopharynx carcinoma

head and neck squamous cell carcinoma



Age Groups: adult senior

Additional content available in CKB BOOST